Evaxion A-S

Insider activity reveals Marianne Soegaard’s 3.36M‑share stake and warrant strategy at Evaxion A‑S, hinting at potential dilution and future upside.

Insider Wegner Staal keeps Evaxion A‑S shares steady, hinting confidence as the biotech eyes clinical milestones and a possible valuation boost.

CEO’s steady 2.29 M share holding at Evaxion shows confidence in AI‑driven vaccine pipeline, hinting at a future rebound for the stock.

Evaxion A‑S insider holdings show strong confidence in its AI‑driven vaccine pipeline—CSO, CFO, and CAIO hold shares and long‑term warrants, signaling future capital inflows as clinical milestones unfold.

CEO‑held shares and warrant vesting show Evaxion’s leadership confidence ahead of AACR data releases, hinting at future partnership and value‑creation opportunities.